| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.025 |
0.025 |
0.0125 － 0.05 |
Garenoxacin (T-3811, BMS-284756) |
17 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.03 |
0.06 |
0.015 － 0.06 |
Moxifloxacin (BAY 12-8039, Avelox) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.03 |
0.12 |
0.03 － 0.12 |
Garenoxacin (T-3811, BMS-284756) |
102 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.05 |
0.05 |
0.0125 － 0.1 |
Trovafloxacin (Trovan) |
17 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 0.12 |
Grepafloxacin (Raxar) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
≤0.06 |
≤0.06 |
≤0.06 － 0.12 |
Moxifloxacin (BAY 12-8039, Avelox) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.06 |
0.12 |
≤0.06 － 1 |
Sparfloxacin (AT-4140, Zagam) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.06 |
0.25 |
0.03 － 1 |
Gatifloxacin (Tequin) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
0.25 |
0.06 － 0.25 |
Moxifloxacin (BAY 12-8039, Avelox) |
102 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
0.25 |
≤0.06 － 0.5 |
Levofloxacin (Levaquin, Quixin) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
0.25 |
0.06 － 2 |
Levofloxacin (Levaquin, Quixin) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.12 |
0.25 |
0.12 － 0.25 |
Gatifloxacin (Tequin) |
102 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.25 |
0.5 |
0.12 － 0.5 |
Ciprofloxacin (Planktonic) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.25 |
0.5 |
0.12 － 1 |
Ofloxacin (Floxin) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.25 |
>8 |
0.12 － >8 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.39 |
0.39 |
0.1 － 0.78 |
Levofloxacin (Levaquin, Quixin) |
17 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
0.5 |
1 |
0.12 － 8 |
Tobramycin (Tobrex, Nebcin) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
1 |
1 |
0.12 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
1 |
>8 |
0.5 － >8 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1467 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
64 |
256 |
0.12 － >256 |
Gentamicin (Gentamycin, Garamycin) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
≤- |
≤0.06 |
≤0.06 － 0.12 |
Clinafloxacin (PD 127391) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
- |
1 |
≤0.06 － 2 |
Clinafloxacin (PD 127391) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
- |
1 |
≤0.06 － 4 |
Clinafloxacin (PD 127391) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
- |
1 |
≤0.06 － 4 |
Quinupristin/Dalfopristin (Synercid) |
21 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
- |
- |
0.03 － >32 |
Imipenem |
102 |
| Staphylococcus aureus (ciprofloxacin-susceptible + methicillin-resistant) |
- |
- |
0.1 － 1.56 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
17 |